EMPLOYMENT AGREEMENTEmployment Agreement • February 27th, 2020 • Orchard Therapeutics PLC • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledFebruary 27th, 2020 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is made by and between Orchard Therapeutics plc (the “Parent”), Orchard Therapeutics North America, a California corporation (the “U.S. Subsidiary”), and Frank Thomas (the “Executive”), and is effective upon the date it is fully executed (the “Effective Date”). The Parent, the U.S. Subsidiary, and their respective subsidiaries and other affiliates are collectively referred to herein as the “Company,” and the duties of the Company set forth in this Agreement may be discharged by any entity within that definition. Except with respect to the Equity Documents and subject to Section 10 below, this Agreement fully supersedes and replaces in all respects all prior agreements between the parties regarding the subject matter herein, including without limitation (i) the offer letter between Orchard Therapeutics Limited (a subsidiary of the Parent) and the Executive dated January 12, 2018 and (ii) any other offer letter, employment agreement or severance ag
EMPLOYMENT AGREEMENTEmployment Agreement • February 27th, 2020 • Orchard Therapeutics PLC • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledFebruary 27th, 2020 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is made by and between Orchard Therapeutics plc (the “Parent”), Orchard Therapeutics North America, a California corporation (the “U.S. Subsidiary”), and Mark Rothera (the “Executive”), and is effective upon the date it is fully executed (the “Effective Date”). The Parent, the U.S. Subsidiary, and their respective subsidiaries and other affiliates are collectively referred to herein as the “Company,” and the duties of the Company set forth in this Agreement may be discharged by any entity within that definition. Except with respect to the Equity Documents and subject to Section 10 below, this Agreement fully supersedes and replaces in all respects all prior agreements between the parties regarding the subject matter herein, including without limitation (i) the Employment Agreement between the U.S. Subsidiary and the Executive dated June 12, 2017 and (ii) any other offer letter, employment agreement or severance agreement between the Executive and